01 September 1998
The microbiological profile of bacterial infections seen in surgical intensive care units (ICU)
Antoni M. Szczepanik, Lucyna Polakiewicz, Jerzy P. Wordliczek, Aldona Kubisz, Jarosław B. GarlickiMed Sci Monit 1998; 4(5): CR807-810 :: ID: 502004
Abstract
Infections are the main problem encountered in intensive care units (ICU). They may be considered as primary,leading to the admission of patients to the ICU or as hospital acquired infection complications. We analyzed the microbiological material of patients treated during the period of 1993-1995, in whom we diagnosed infections of various location. During this period, we treated 582 patients, 74% following surgical procedures.Primary and acquired infections were noted in 262 patients, out of which 36 had more than one infection focus. In 44% of cases, cultures demonstrated the presence of more than one pathogen. Pulmonary infections composed 42% of all infections, intraabdominal infections - 27%, urinary tract infections - 9%, infections accompanying the use of intravenous catheters - 8%, wound infections - 6% and other infections - 8%. Most often, we isolated gram negative (E. coli, pseudomonas aeruginosa) bacteria from cultures, but the percentage of gram positive bacteria had increased during the three year period from 17.3 to 25%. Out of Pseudomonas strains, the resistance profile changed with time. During the first year of observation, we noted single cases of resistance towards imipinem, while resistance towards other antibiotics, such as ceftazidim was 20% and quinolones and aminoglycosides 30-45%. In 1995 the resistance towards imipenem increased to 16.6%, for ciprofloxacine - 58% and in the case of aminoglycosides 30-35%. The biggest group out of pluriresistant strains comprised the Enterococcus strains, although we found no vancomycin resistant strain. We observed an increase in resistance towards quinolones (pefloxacin and ciprofloxacin).
Keywords: Intensive Care Units
Editorial
01 March 2024 : Editorial
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaDOI: 10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
In Press
18 Mar 2024 : Clinical Research
Sexual Dysfunction in Women After Tibial Fracture: A Retrospective Comparative StudyMed Sci Monit In Press; DOI: 10.12659/MSM.944136
21 Feb 2024 : Clinical Research
Potential Value of HSP90α in Prognosis of Triple-Negative Breast CancerMed Sci Monit In Press; DOI: 10.12659/MSM.943049
22 Feb 2024 : Review article
Differentiation of Native Vertebral Osteomyelitis: A Comprehensive Review of Imaging Techniques and Future ...Med Sci Monit In Press; DOI: 10.12659/MSM.943168
23 Feb 2024 : Clinical Research
A Study of 60 Patients with Low Back Pain to Compare Outcomes Following Magnetotherapy, Ultrasound, Laser, ...Med Sci Monit In Press; DOI: 10.12659/MSM.943732
Most Viewed Current Articles
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952